Tyrosine Kinase Inhibitors  >>  Phase 4


«123
Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 03326649961328166019922324265629883320
            
            
             
Aybintio (bevacizumab biosimilar) / Samsung, Mundipharma           
          
            
             
Nailike (olverembatinib) / Takeda           
          
            
             
Turalio (pexidartinib) / Daiichi Sankyo           
          
            
             
Cipterbin (inetetamab) / 3SBio           
          
            
             
Exubera (recombinant human insulin inhalational) / Nektar Therap           
          
            
             
Increlex (mecasermin) / Eton Pharma           
          
            
             
Soliqua 100/33 (lixisenatide/insulin glargine) / Sanofi           
          
            
             
Vabysmo (faricimab-svoa) / Roche           
          
            
             
Insulatard (isophane insulin) / Novo Nordisk           
          
            
             
Hansoh Xinfu (flumatinib) / Jiangsu Hengrui Pharma, Jiangsu Hansoh Pharma           
          
            
             
Ayvakit (avapritinib) / Blueprint Medicines           
          
            
             
Defitelio (defibrotide) / IRCCS San Raffaele Hospital, Jazz           
          
            
             
Vitrakvi (larotrectinib) / Bayer           
          
            
             
Basaglar (insulin glargine biosimilar) / Boehringer Ingelheim, Eli Lilly           
          
            
             
Herzuma (trastuzumab-pkrb) / Nippon Kayaku, Mundipharma, Celltrion, Teva           
          
            
             
Tepezza (teprotumumab-trbw) / Roche, Amgen           
          
            
             
Gavreto (pralsetinib) / Rigel           
          
            
             
vadimezan (ASA404) / Antisoma           
          
            
             
Klisyri (tirbanibulin ointment) / Hanmi, Almirall, Athenex, PharmaEssentia           
          
            
             
bozitinib (APL-101) / Apollomics           
          
            
             
Humulin N (isophane insulin) / Eli Lilly           
          
            
             
Novolin N (isophane insulin) / Novo Nordisk           
          
            
             
Semena (befotertinib) / InventisBio, Betta Pharma           
          
            
             
Qi Xinke (iruplinalkib) / Qilu Pharma           
          
            
             
Susvimo (ranibizumab port delivery system) / Roche           
          
            
             
Eylea HD (high-dose aflibercept) / Regeneron           
          
            
             
Haiyitan (gumarontinib) / HaiHe Biopharma           
          
            
             
Hercessi (trastuzumab-strf) / Fosun Pharma, Intas           
          
            
             
Humalog ILPS (insulin lispro protamine suspension) / Eli Lilly           
          
            
             
Humalog Mix75/25 Kwikpen (lispro protamine/ lispro) / Eli Lilly           
          
            
             
Ontruzant (trastuzumab-dttb) / Samsung, AffaMed Therap, Mundipharma, Organon           
          
            
             
tirbanibulin oral (KX2-391 oral) / Athenex           
          
            
             
Ankeda (bevacizumab biosimilar) / Qilu Pharma           
          
            
             
Insuman Rapid (recombinant human insulin) / Sanofi           
          
            
             
Lispro-PH20 (insulin lispro/rHuPH20) / Halozyme           
          
            
             
Neovasculgen (PI-VEGF165) / Human Stem Cells Institute           
          
            
             
Xeljanz XR (tofacitinib XR) / Pfizer           
          
            
             
Aspart-PH20 (insulin aspart/rHuPH20) / Halozyme           
          
            
             
Basalin (insulin glargine biosimilar) / Gan & Lee Pharma, LG Chem, Sandoz           
          
            
             
Insuman Basal (isophane insulin) / Sanofi           
          
            
             
Novolin 70/30 (isophane insulin 70%/recombinant human insulin 30%) / Novo Nordisk           
          
            
             
Humalog Mix 50/50 (insulin lispro protamine 50% + insulin lispro 50%) / Eli Lilly           
          
            
             
Prandilin (insulin lispro biosimilar) / Gan & Lee Pharma, Sandoz           
          
            
             
ZemiSU (gemigliptin/glimepiride) / LG Chem           
          
            
             
Insuman Comb 25 (biphasic isophane insulin suspension consisting of 25% dissolved insulin and 75% crystalline protamine insulin) / Sanofi           
          
            
            


«123